Janus Henderson Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $32.6M | Sell |
|
|||||
|
2021
Q1 | $98.3M | Sell |
|
|||||
|
2020
Q4 | $421M | Buy |
|
|||||
|
2020
Q3 | $177M | Buy |
|
|||||
|
2020
Q2 | $26.2M | Buy |
|
|||||
|
2020
Q1 | $13.8M | Buy |
|
|||||
|
2019
Q4 | $8.25M | Sell |
|
|||||
|
2019
Q3 | $16.4M | Sell |
|
|||||
|
2019
Q2 | $81.9M | Sell |
|
|||||
|
2019
Q1 | $179M | Buy |
|
|||||
|
2018
Q4 | $99.5M | Buy |
|
|||||
|
2018
Q3 | $137M | Sell |
|
|||||
|
2018
Q2 | $132M | Sell |
|
|||||
|
2018
Q1 | $134M | Sell |
|
|||||
|
2017
Q4 | $156M | Buy |
|
|||||
|
2017
Q3 | $145M | Sell |
|
|||||
|
2017
Q2 | $139M | Buy |
|
|||||
|
2017
Q1 | $7.73M | Sell |
|
|||||
|
2016
Q4 | $7.99M | Sell |
|
|||||
|
2016
Q3 | $8.01M | Sell |
|
|||||
|
2016
Q2 | $8.04M | Sell |
|
|||||
|
2016
Q1 | $10.2M | Buy |
|
|||||
|
2015
Q4 | $5.87M | Sell |
|
|||||
|
2015
Q3 | $4.82M | Buy |
|
|||||
|
2015
Q2 | $5.05M | Sell |
|
|||||
|
2015
Q1 | $4.89M | Hold |
|
|||||
|
2014
Q4 | $5.22M | Hold |
|
|||||
|
2014
Q3 | $4.68M | Hold |
|
|||||
|
2014
Q2 | $4.41M | Hold |
|
|||||
|
2014
Q1 | $4.29M | Buy |
|
|||||
|
2013
Q4 | $2.94M | Hold |
|
|||||
|
2013
Q3 | $2.57M | Sell |
|
|||||
|
2013
Q2 | $2.21M | Buy |
|